Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Helpful Resources
Liver Health MD
Healthy Liver Hacks: A New Resource for Patients
Understanding liver health is an important first step. Knowing how to put that knowledge into everyday practice matters too.
We are pleased to share Healthy Liver Hacks by Dr. Supriya Joshi, a gastroenterologist, hepatologist and member of our Board of Directors.
Her new book brings together more than 175 practical tips covering liver health, nutrition, movement, sleep and metabolic health. It explores how the liver works and offers approachable ways to build habits that support overall health.
For patients and families looking to better understand fatty liver disease, this is a new resource to explore alongside conversations with their healthcare team.
We are proud of Dr. Joshi’s commitment to patient education and delighted to celebrate this publication. Congratulations, Supriya!
Learn more or purchase Healthy Liver Hacks on Amazon Canada
Available in US from Amazon too: https://www.amazon.com/s?k=supriya+joshi&crid=3GXR1E8FYF978&sprefix=supriya+joshi%2Caps%2C812&ref=nb_sb_noss
Instagram Link:
Liver Health MD
Dr. Supriya Joshi, Hepatologist, and FLA Board member, shares insights into the world of fatty liver disease - NAFLD and NASH, now referred to as MASLD and MASH. With 14,000 followers and growing, Dr. Joshi openly shares her thoughts as an expert to help you navigate the world with a healthy liver and a healthy life.
Instagram Link:
Need-to-Know NAFLD
Description
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the obesity and metabolic syndrome epidemics, which this up-to-date book deals with comprehensively. The contents outline disease mechanisms, diagnostic tests, management, varying manifestations, and special populations. It covers the mechanistic pathways that contribute to NAFLD development, including the role of genetic variants and the gut microbiome. It elaborates on noninvasive diagnostic tests to screen for NAFLD, determine its severity, and monitor response to lifestyle intervention and pharmacologic treatment. This book helps clinicians diagnose and treat this common and potentially deadly disease.
Key Features:
- Reviews current drugs in development and provides practical advice to clinicians on the diagnosis and management of fatty liver.
- Proves attractive to primary care providers who are on the front line of managing patients with NAFLD, to gastroenterologists and hepatologists who would benefit from updated data on how to risk-stratify patients and identify those who will be eligible for pharmacologic treatment, and other specialists such as cardiologists, endocrinologists, and nephrologists who will find this book to be a useful reference on the extrahepatic manifestations of NAFLD.
- Focuses on extrahepatic manifestations and new insights on the mechanistic drivers of the disease.
A multi-society Delphi consensus statement on new fatty liver disease nomenclature
There is new nomenclature for fatty liver disease. The change from NAFLD and NASH to MASLD and MASH has happened, and here is the background in the original published Hepatology journal paper.